Results 181 to 190 of about 2,886,262 (322)

Clinical assessment of early brain function in infants with congenital heart disease [PDF]

, 2018
Mirthe J. Mebius, Arend F. Bos
openalex   +1 more source

Prediction Model for Etiologic Differentiation of Isolated Vestibular Syndrome in Emergency Settings

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to develop and validate a predictive model for differentiating central from peripheral etiologies in patients with isolated vestibular syndrome (VS). Methods In this multicenter retrospective cohort study, 506 patients with isolated VS from five hospitals were divided into derivation (n = 301) and validation (n = 205)
Guo Wenting, Du Liping, Yang Yi, Hu Jin, Ye Bijun, Wang Jianer, Liu Shuangsi, Guo Shunyuan, Cai Xiaofeng, Wang Huiyuan, Wu Bin, Yu Xiang, Shi Tianming   +12 more
wiley   +1 more source

Normalization and cross-entropy connectivity in brain disease classification. [PDF]

iScience
Wu H, Li S, Zeng Y.
europepmc   +1 more source

Deep brain stimulation under general anaesthesia for Parkinson's disease: A retrospective evaluation of perioperative events and anaesthetic management after switching away from conscious sedation [PDF]

Marta García-Orellana, Felipe Maldonado, Paola Hurtado, Gabriel Pujol Fontrodona, Pedro Roldán, Alejandra Mosteiro, Jordi Rumià, Almudena Sánchez‐Gómez, Nicolás de Riva, Neus Fàbregas, Isabel Gracia, J. Tercero, Eugènia Pujol‐Ayach, R. Valero   +13 more
openalex   +1 more source

Accelerated Progression of Gait Impairment in Parkinson's Disease and REM Sleep Without Atonia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective People with Parkinson's disease (PD) and rapid eye movement (REM) sleep without atonia (RSWA) often have more severe gait disturbances compared to PD without RSWA. The association between the presence and expression of RSWA and the rate of progression of gait impairment in PD is unknown.
Sommer L. Amundsen‐Huffmaster, Jae Woo Chung, Maria E. Linn‐Evans, Matthew N. Petrucci, Chiahao Lu, Destiny J. Weaver, Joshua De Kam, Scott E. Cooper, Paul J. Tuite, Aleksandar Videnovic, Michael J. Howell, Colum D. MacKinnon   +11 more
wiley   +1 more source

3D <i>in vitro</i> blood-brain barrier models: recent advances and their role in brain disease research and therapy. [PDF]

Front Pharmacol
O'Halloran L, Akinsete O, Kogan AL, Wrona M, Mahdi AF.   +4 more
europepmc   +1 more source

Extracellular Matrix Regulation in Physiology and in Brain Disease. [PDF]

Int J Mol Sci, 2023
Soles A, Selimovic A, Sbrocco K, Ghannoum F, Hamel K, Moncada EL, Gilliat S, Cvetanovic M.   +7 more
europepmc   +1 more source

Mitochondrial function and Aβ in Alzheimer's disease postmortem brain

, 2022
Benjamin Troutwine, Taylor A. Strope, Edziu Franczak, Colton R Lysaker, Laylan Hamid, Clayton Mansel, Julia A. Stopperan, Cynthia M. Gouvion, Mohammad Haeri, Russell H. Swerdlow, Heather Wilkins   +10 more
openalex   +1 more source

CSF Levels of NPTX2 Are Associated With Less Brain Atrophy Over Time in Cognitively Unimpaired Individuals

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Neuronal pentraxin 2 (NPTX2) is a synaptic protein involved in synaptic plasticity and regulation of neuronal excitability. Lower baseline cerebrospinal fluid (CSF) NPTX2 levels have been shown to be associated with an earlier onset of mild cognitive impairment (MCI), a pre‐dementia syndrome, even after CSF Alzheimer's Disease (AD)
Juan P. Vazquez, Corinne Pettigrew, Yuxin Zhu, Claire Anderson, Guray Erus, Christos Davatzikos, Michael Miller, Abhay Moghekar, Sungtaek Oh, Chan‐Hyun Na, Marilyn Albert, Paul Worley, Anja Soldan   +12 more
wiley   +1 more source

On Levodopa Interactions with Brain Disease Amyloidogenic Proteins at the Nanoscale. [PDF]

ACS Omega
Bergaglio T, Kummer N, Bhattacharya S, Thompson D, Campioni S, Nirmalraj PN.   +5 more
europepmc   +1 more source